170 related articles for article (PubMed ID: 32032816)
21. Cross-sectional Associations of β-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies.
Ferreira D; Przybelski SA; Lesnick TG; Schwarz CG; Diaz-Galvan P; Graff-Radford J; Senjem ML; Fields JA; Knopman DS; Jones DT; Savica R; Ferman TJ; Graff-Radford N; Lowe VJ; Jack CR; Petersen RC; Westman E; Boeve BF; Kantarci K
Neurology; 2023 Feb; 100(8):e846-e859. PubMed ID: 36443011
[TBL] [Abstract][Full Text] [Related]
22.
Nicastro N; Surendranathan A; Mak E; Rowe JB; O'Brien JT
Ann Clin Transl Neurol; 2019 Oct; 6(10):2133-2136. PubMed ID: 31507085
[TBL] [Abstract][Full Text] [Related]
23. Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study.
Wolters EE; van de Beek M; Ossenkoppele R; Golla SSV; Verfaillie SCJ; Coomans EM; Timmers T; Visser D; Tuncel H; Barkhof F; Boellaard R; Windhorst AD; van der Flier WM; Scheltens P; Lemstra AW; van Berckel BNM
Neuroimage Clin; 2020; 28():102504. PubMed ID: 33395993
[TBL] [Abstract][Full Text] [Related]
24. A combined VBM and DTI study of schizophrenia: bilateral decreased insula volume and cerebral white matter disintegrity corresponding to subinsular white matter projections unlinked to clinical symptomatology.
Onay A; Yapıcı Eser H; Ulaşoğlu Yıldız Ç; Aslan S; Talı ET
Diagn Interv Radiol; 2017; 23(5):390-397. PubMed ID: 28870884
[TBL] [Abstract][Full Text] [Related]
25. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.
Nedelska Z; Senjem ML; Przybelski SA; Lesnick TG; Lowe VJ; Boeve BF; Arani A; Vemuri P; Graff-Radford J; Ferman TJ; Jones DT; Savica R; Knopman DS; Petersen RC; Jack CR; Kantarci K
Neuroimage Clin; 2018; 19():939-947. PubMed ID: 30003031
[TBL] [Abstract][Full Text] [Related]
26. Relevance of subcortical visual pathways disruption to visual symptoms in dementia with Lewy bodies.
Delli Pizzi S; Maruotti V; Taylor JP; Franciotti R; Caulo M; Tartaro A; Thomas A; Onofrj M; Bonanni L
Cortex; 2014 Oct; 59():12-21. PubMed ID: 25113955
[TBL] [Abstract][Full Text] [Related]
27. White matter changes in dementia with Lewy bodies and Alzheimer's disease: a tractography-based study.
Kiuchi K; Morikawa M; Taoka T; Kitamura S; Nagashima T; Makinodan M; Nakagawa K; Fukusumi M; Ikeshita K; Inoue M; Kichikawa K; Kishimoto T
J Psychiatr Res; 2011 Aug; 45(8):1095-100. PubMed ID: 21315376
[TBL] [Abstract][Full Text] [Related]
28.
Nicastro N; Rodriguez PV; Malpetti M; Bevan-Jones WR; Simon Jones P; Passamonti L; Aigbirhio FI; O'Brien JT; Rowe JB
J Neurol; 2020 Feb; 267(2):341-349. PubMed ID: 31641878
[TBL] [Abstract][Full Text] [Related]
29. Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer's disease.
Blanc F; Colloby SJ; Cretin B; de Sousa PL; Demuynck C; O'Brien JT; Martin-Hunyadi C; McKeith I; Philippi N; Taylor JP
Alzheimers Res Ther; 2016 Jul; 8():31. PubMed ID: 27484179
[TBL] [Abstract][Full Text] [Related]
30. Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study.
Bozzali M; Falini A; Cercignani M; Baglio F; Farina E; Alberoni M; Vezzulli P; Olivotto F; Mantovani F; Shallice T; Scotti G; Canal N; Nemni R
Brain; 2005 Jul; 128(Pt 7):1595-604. PubMed ID: 15817515
[TBL] [Abstract][Full Text] [Related]
31. Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study.
Watson R; O'Brien JT; Barber R; Blamire AM
Int Psychogeriatr; 2012 Apr; 24(4):532-40. PubMed ID: 22126938
[TBL] [Abstract][Full Text] [Related]
32. Multimodal neuroimaging relationships in progressive supranuclear palsy.
Sintini I; Schwarz CG; Senjem ML; Reid RI; Botha H; Ali F; Ahlskog JE; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
Parkinsonism Relat Disord; 2019 Sep; 66():56-61. PubMed ID: 31279635
[TBL] [Abstract][Full Text] [Related]
33. Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies.
Mak E; Gabel S; Su L; Williams GB; Arnold R; Passamonti L; Vazquez Rodríguez P; Surendranathan A; Bevan-Jones WR; Rowe JB; O'Brien JT
Int Psychogeriatr; 2017 Apr; 29(4):545-555. PubMed ID: 28088928
[TBL] [Abstract][Full Text] [Related]
34. In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.
Fodero-Tavoletti MT; Smith DP; McLean CA; Adlard PA; Barnham KJ; Foster LE; Leone L; Perez K; Cortés M; Culvenor JG; Li QX; Laughton KM; Rowe CC; Masters CL; Cappai R; Villemagne VL
J Neurosci; 2007 Sep; 27(39):10365-71. PubMed ID: 17898208
[TBL] [Abstract][Full Text] [Related]
35. Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia.
Malpetti M; Cope TE; Street D; Jones PS; Hezemans FH; Mak E; Tsvetanov KA; Rittman T; Bevan-Jones WR; Patterson K; Passamonti L; Fryer TD; Hong YT; Aigbirhio FI; O'Brien JT; Rowe JB
Brain; 2023 Aug; 146(8):3221-3231. PubMed ID: 36883644
[TBL] [Abstract][Full Text] [Related]
36. Amyloid-β-related and unrelated cortical thinning in dementia with Lewy bodies.
Lee YG; Jeon S; Yoo HS; Chung SJ; Lee SK; Lee PH; Sohn YH; Yun M; Evans AC; Ye BS
Neurobiol Aging; 2018 Dec; 72():32-39. PubMed ID: 30205358
[TBL] [Abstract][Full Text] [Related]
37. Association between human gray matter metabotropic glutamate receptor-5 availability in vivo and white matter properties: a [
Kim SE; Joo YH; Son YD; Kim HK; Lee SY; Lee MW; Ido T; Kim JH
Brain Struct Funct; 2020 Jul; 225(6):1805-1816. PubMed ID: 32495131
[TBL] [Abstract][Full Text] [Related]
38. Assessment of regional MR diffusion changes in dementia with Lewy bodies and Alzheimer's disease.
O'Donovan J; Watson R; Colloby SJ; Blamire AM; O'Brien JT
Int Psychogeriatr; 2014 Apr; 26(4):627-35. PubMed ID: 24331205
[TBL] [Abstract][Full Text] [Related]
39. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
Iizuka T; Kameyama M
Ann Nucl Med; 2016 Jul; 30(6):421-9. PubMed ID: 27098829
[TBL] [Abstract][Full Text] [Related]
40. Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies.
Ferreira D; Nedelska Z; Graff-Radford J; Przybelski SA; Lesnick TG; Schwarz CG; Botha H; Senjem ML; Fields JA; Knopman DS; Savica R; Ferman TJ; Graff-Radford NR; Lowe VJ; Jack CR; Petersen RC; Lemstra AW; van de Beek M; Barkhof F; Blanc F; Loureiro de Sousa P; Philippi N; Cretin B; Demuynck C; Hort J; Oppedal K; Boeve BF; Aarsland D; Westman E; Kantarci K
Neurobiol Aging; 2021 Sep; 105():252-261. PubMed ID: 34130107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
